Annals of the Rheumatic Diseases
IF
16.10
Papers
50017
Papers 10000
1 page of 1,000 pages (10k results)
Newest
#1Lionel SpielmannH-Index: 4
#2Benoit NespolaH-Index: 4
Last. Alain MeyerH-Index: 27
view all 3 authors...
We thank Ogawa-Momohara et al for their comment1 on our work in which we identified that anti-Ku patients with elevated serum creatine kinase (elevated CK) are at risk of interstitial lung disease (ILD), whereas anti-Ku patients with anti-double-strand DNA (dsDNA) antibodies frequently have systemic lupus erythematosus (SLE) and are at risk of glomerulonephritis.2 The data reported by Ogawa-Momohara et al importantly complete our results since none of our anti-Ku patients had an Asian origin. …
Source
#1Yi-Sheng LiouH-Index: 7
#2Tsung-Kun LinH-Index: 3
Last. Gwo-Ping JongH-Index: 7
view all 4 authors...
Statins have been widely used to control dyslipidaemia, and there is strong evidence for beneficial effects for patients at risk for cardiovascular diseases.1 2 In particular, statins may influence bone metabolism by increasing bone formation.3 4 Recently, Ozen et al 5 reported that medication with opioids, selective serotonin reuptake inhibitors, and glucocorticoids were associated with an increased risk of osteoporosis-related site fractures (vertebra, hip, forearm and humerus) in patients wit...
3 CitationsSource
#1Shih-Wei LaiH-Index: 27
#2Yu-Hung KuoH-Index: 5
Last. Kuan-Fu LiaoH-Index: 18
view all 3 authors...
Ankylosing spondylitis is a long-term inflammatory disease that always affects the spine joints. The association between ankylosing spondylitis and other diseases has been extensively assessed.1 2 Recently a cohort study conducted by Schreiber et al published in Annals of the Rheumatic Diseases found that the new-onset cases of inflammatory bowel disease were uncommon in patients with ankylosing spondylitis on secukinumab therapy (1.13%, 9/794).3 In order to examine the association between ankyl...
2 CitationsSource
#1Young Ho Lee (KU: Korea University)H-Index: 8
#2Gwan Gyu Song (KU: Korea University)H-Index: 46
We read with interest the article by Liao et al 1 regarding diabetes mellitus in ankylosing spondylitis and the meta-analysis by Mathieu et al . This nationwide cohort study demonstrated that the overall incidence of diabetes mellitus was 1.21-fold higher in the ankylosing spondylitis group than in the non-ankylosing spondylitis group,1 and Mathieu et al ’s research showed an increased cardiovascular events in ankylosing spondylitis.2 The results of Liao et al are …
Source
I read with interest the paper ‘Novel NLRP12 variant presenting with familial cold autoimmunity syndrome phenotype’ by Gupta et al in one of the issues in your esteemed journal.1 We have reported another patient with a different site of mutation in the same gene from another part of India earlier this year.2 Compared with the patient under discussion our patient had a milder phenotype in the form of recurrent fever, abdominal pain, nausea and vomiting lasting for 4–5 days every month along with ...
2 CitationsSource
#1Francesca Minoia (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 17
#2Angelo Ravelli (UniGe: University of Genoa)H-Index: 90
We are grateful to Wang et al 1 for testing our diagnostic score for macrophage activation syndrome (MAS)2 in their patients with adult onset Still disease (AOSD). Because it is increasingly recognised that systemic juvenile idiopathic arthritis (sJIA) and AOSD represent the same disease occurring at different ages3 4 and considering that the two illnesses share a similar risk for MAS, it is important to investigate whether the current diagnostic tools are applicable to both conditions. Wang and...
1 CitationsSource
#1Mirko Manetti (UniFI: University of Florence)H-Index: 32
#2Marco Matucci-Cerinic (UniFI: University of Florence)H-Index: 95
The recent paper by Matei et al 1 has raised our interest on the feasibility and reliability of vascularised human skin equivalents for fibrosis research. This is a novel in vitro model which may replicate key features of fibrotic skin and may become a valuable platform for preclinical testing of innovative therapeutic strategies for systemic sclerosis (SSc) and other cutaneous fibrosing conditions. In this informative study, an engineered human skin equivalent featuring a functional vascular sy...
2 CitationsSource
#1A. E. Matei (FAU: University of Erlangen-Nuremberg)H-Index: 4
#2Jörg H W Distler (FAU: University of Erlangen-Nuremberg)H-Index: 87
We would like to thank Dr Manetti and Prof Matucci-Cerinic1 for their stimulating letter on our manuscript.2 The authors discuss strengths and potential limitations of vascularised skin equivalents as a novel in vitro model for systemic sclerosis (SSc). They raise two key points: 1. Although the model includes key populations of cells relevant to skin homeostasis and to the pathogenesis of SSc such as fibroblasts, endothelial cells and keratinocytes, other relevant cell populations are not inclu...
Source
#1Si Wu (NU: Nanjing University)H-Index: 1
#2Xiaojun Tang (NU: Nanjing University)H-Index: 11
Last. Xuebing Feng (NU: Nanjing University)H-Index: 28
view all 5 authors...
We read with great interest the article by Sabbagh et al demonstrating that anti-Ro52 autoantibodies were connected with the development of interstitial lung disease (ILD) in patients with juvenile myositis.1 Anti-Ro52 has been found in a variety of connective tissue diseases (CTDs) and drawn considerable attention from rheumatologists in recent years. Besides myositis, these autoantibodies have also been reported to be related to ILD in several other CTDs, but with great discrepancy across the ...
4 CitationsSource
#1Ran Wang (SJTU: Shanghai Jiao Tong University)H-Index: 5
#2Ting Li (SJTU: Shanghai Jiao Tong University)H-Index: 39
Last. Qiong Fu (SJTU: Shanghai Jiao Tong University)H-Index: 12
view all 8 authors...
We read with great interest the article by Minoia et al which named development and initial validation of the macrophage activation syndrome (MAS)/systemic juvenile idiopathic arthritis (sJIA) (MS) score for diagnosis of MAS in sJIA. MAS is a life-threatening complication of rheumatic disorders, including sJIA, adult-onset Still’s disease (AOSD) and lupus.1–4 Timely diagnosis and appropriate treatment of MAS are particularly important to improve the prognosis of MAS patients. At present, hemopha...
6 CitationsSource
12345678910
Top fields of study
Internal medicine
Physical therapy
Immunology
Arthritis
Rheumatoid arthritis
Diabetes mellitus
Medicine